Descriptive and Retrospective Study on the Prevalence of Overweight and Obesity among Patients with Type 2 Diabetes Mellitus

Weight gain has been declared as one of the top 10 global health risks by the World Health Organization (WHO). In the past few decades, obesity has increased alarmingly around the world. Most patients with type 1 diabetes possess anti-insulin antibodies before receiving insulin therapy. About 80% of patients with type 1 diabetes have circulating islet cell antibodies. Both developed and developing countries are facing a medical disaster due to obesity. The incidence of type 2 diabetes is correlated with insulin resistance. Insulin resistance does not lead to hyperglycemia in most obese individuals. The purpose of this study is to determine whether Type 2 diabetes mellitus patients are overweight or obese, and to identify risk factors for such disease. Preventing diabetes complications and reducing its prevalence. A study was conducted to determine whether obesity increases the risk of diabetes. Identify dyslipidemia in Type 2 diabetics by studying its prevalence pattern. The age range of 40 to 70 years for type 2 diabetes mellitus patients. The study also excluded participants with dyslipidemia. Various metabolic parameters were measured as well as baseline anthropometric indices (BMI, WHR). We found 25 patients in normal weight category, 3 patients in underweight category, 50 patients in overweight category, and 53 patients in obese category among the patients aged 40-50 years. Developing appropriate and controlled strategies for improving nutrition and promoting weight loss is urgently needed to mitigate Type 2 diabetes patients' increasing health challenges.